FDA Analyte-Specific Reagent Guidance Spells Out Small Lab Fundamentals
This article was originally published in The Gray Sheet
Executive Summary
Labeling and promotional material for Class I analyte-specific reagents may bear information clarifying that FDA does not require premarket review of the tests, according to the agency